According to SpringWorks Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.87. In 2022 the company made an earnings per share (EPS) of -$5.21 a decrease over its 2021 EPS that were of -$3.59.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.87 | -6.53% |
2022 | -$5.21 | 45.13% |
2021 | -$3.59 | 241.9% |
2020 | -$1.05 | -60.28% |
2019 | -$2.64 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -55.24% | ๐บ๐ธ USA |